BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 11:24:03 AM | Browse: 163 | Download: 417
 |
Received |
|
2025-05-30 06:19 |
|
Peer-Review Started |
|
2025-05-30 06:19 |
|
First Decision by Editorial Office Director |
|
2025-06-12 07:54 |
|
Return for Revision |
|
2025-06-12 07:54 |
|
Revised |
|
2025-06-25 23:08 |
|
Publication Fee Transferred |
|
2025-07-15 17:03 |
|
Second Decision by Editor |
|
2025-08-15 02:54 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-15 08:53 |
|
Articles in Press |
|
2025-08-15 08:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-17 03:16 |
|
Publish the Manuscript Online |
|
2025-09-25 11:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mohammed Ewid, Hossam Sherif, Nazmus Saquib, Ammar Mohammed Alammari, Amro Abdelaziz Mohammed Ismail, Mohammed H Alkahlot, Ziyad T Ahmed, Faisal Zain Mohammed Al-Zabidi and Nawaf Al Mutiri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohammed Ewid, MD, Department of Internal Medicine, College of Medicine, Sulaiman Al Rajhi University, Post Office Box 777, Bukaryiah 51941, Saudi Arabia. drmohammedowid@gmail.com |
| Key Words |
Albumin-bilirubin score; Direct-acting antiviral agents; Chronic hepatitis C; Liver fibrosis; Liver function |
| Core Tip |
The albumin-bilirubin score is a simple and reproducible score that showed significant improvement following direct-acting antivirals treatment in patients with chronic hepatitis C virus infection. Moreover, it predicted advanced liver fibrosis with a sensitivity of 60% and a specificity of 83% at a cut-off value of -2.38. Accordingly, it could be utilized to monitor liver function and to determine the extent of liver fibrosis among those patients. |
| Publish Date |
2025-09-25 11:24 |
| Citation |
Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. World J Hepatol 2025; 17(9): 110049 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i9/110049.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i9.110049 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
